Bharat Biotech’s Intranasal COVID Vaccine Gets CDSCO Nod For Heterologous Booster Doses
Hyderabad: Bharat Biotech International Limited on Monday announced that its COVID-19 intranasal vaccine iNCOVACC (BBV154) has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency…